Skip to main content

Table 1 Gender-stratified characteristics of MetS patients and healthy control subjects

From: Gender disparity in LDL-induced cardiovascular damage and the protective role of estrogens against electronegative LDL

  Men Women Total
  Control (n = 11) MetS (n = 15) Control (n = 15) MetS (n = 15) Control (n = 26) MetS (n = 30)
Age (years) 41.2 ± 9.8 48.9 ± 7.1* 49.3 ± 15.7 53.2 ± 4.4 45.9 ± 13.9 51.1 ± 6.2*
Waist (cm) 88.5 ± 10.6 106.4 ± 12.9** 74.4 ± 8.0# 106.2 ± 15.2** 80.4 ± 11.5 106.3 ± 13.9**
SBP (mmHg) 121.3 ± 9.6 136.2 ± 16.5* 120.1 ± 26.8 120.2 ± 14.8 120.6 ± 21.0 127.5 ± 17.3
DBP (mmHg) 81.5 ± 10.2 83.4 ± 9.8 73.0 ± 14.6 74.5 ± 9.6 76.6 ± 13.4 78.6 ± 10.5
Glucose (mg/dL) 89.2 ± 7.7 142.7 ± 59.1** 85.1 ± 7.4 102.4 ± 19.4** 86.9 ± 7.6 122.5 ± 47.8**
TC (mg/dL) 232.0 ± 47.8 196.9 ± 48.0 224.9 ± 60.0 220.0 ± 59.1 227.9 ± 54.2 208.5 ± 54.2
TG (mg/dL) 151.8 ± 95.0 180.9 ± 151.8 106.3 ± 95.5 144.1 ± 59.0* 125.6 ± 96.2 162.5 ± 114.7
HDL-C (mg/dL) 52.7 ± 15.8 44.0 ± 12.2 62.1 ± 13.7 54.0 ± 19.2 58.1 ± 15.1 49.0 ± 16.6*
LDL-C (mg/dL) 149.0 ± 37.9 120.9 ± 45.3 142.3 ± 52.1 143.9 ± 41.2 145.2 ± 45.9 132.8 ± 44.0
L5 (%) 4.1 ± 5.3 16.9 ± 14.6** 5.1 ± 5.6 10.1 ± 8.5* 4.7 ± 5.4 13.5 ± 12.2**
  1. Values represent the mean ± standard deviation. P-values were determined by using the Wilcoxon rank sum test (Mann–Whitney U test). MetS metabolic syndrome; SBP systolic blood pressure; DBP diastolic blood pressure; TC total cholesterol; TG triglyceride; HDL-C HDL cholesterol; LDL-C LDL cholesterol. *P < 0.05, **P < 0.01 vs gender-matched control group; #P < 0.05 vs male control group.